2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

By F. Mach, C. Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, M. Casula, Lina Badimon, M. J. Chapman, Guy G De Backer, V. Delgado, B. Ference and 112 more. European Heart Journal, 2019

3,945 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/e18e442c082b3336721cfbe3c013de2f21e22eed

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. Børge G. Nordestgaard

In Endocrinology, Diabetes and Metabolism

1. Børge G. Nordestgaard
2. Alberico L. Catapano
3. L. Tokgözoğlu

In Surgery

1. Alberico L. Catapano
2. L. Tokgözoğlu
3. Børge G. Nordestgaard
4. I. Graham

Citations in the corpus

• Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022, background): “Very high Lp(a) levels (>180 mg/dL or >430 nmol/L) also identify individuals with lifetime ASCVD risk equivalent to untreated heterozygous familial hypercholesterolaemia (FH).(126)”